![](/img/cover-not-exists.png)
A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy
Turini, Marc, Chames, Patrick, Bruhns, Pierre, Baty, Daniel, Kerfelec, BrigitteVolume:
5
Journal:
Oncotarget
DOI:
10.18632/oncotarget.2093
Date:
July, 2014
File:
PDF, 1.04 MB
2014